Erik Fredlund

Citado por

	Total	Desde 2019
Citas	6940	3112
Índice h	29	24
Índice i10	36	32

720

360

180

540

20072008200920102011201220132014201520162017201820192020202120222023202463 78 117 217 257 313 379 419 435 463 505 512 547 633 705 540 507 178

Acceso público

Ver todo

25 artículos

2 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Markus RingnérScience for Life Laboratory and Lund UniversityDirección de correo verificada de scilifelab.se
Alexander PietrasLund University | Translational Cancer ResearchDirección de correo verificada de med.lu.se
Pieter Mestdaghpostdoctoral fellow, Ghent UniversityDirección de correo verificada de ugent.be
Jo Vandesompeleprofessor in functional cancer genomics and applied bioinformaticsDirección de correo verificada de ugent.be
Johan StaafDepartment of Oncology, Clinical Sciences, Lund University, SwedenDirección de correo verificada de med.lu.se
Johan Vallon-ChristerssonDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SwedenDirección de correo verificada de med.lu.se
Kris GevaertSenior Full Professor, Ghent University, BelgiumDirección de correo verificada de vib-ugent.be
Katleen De Preterfull research professor, Ghent UniversityDirección de correo verificada de ugent.be
David GisselssonProfessor of Molecular Pathology, Lund UniversityDirección de correo verificada de med.lu.se
Jari HäkkinenDepartment of Oncology and Pathology, Clinical Sciences, Lund University, SwedenDirección de correo verificada de med.lu.se
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityDirección de correo verificada de oncology.ox.ac.uk
Björn MentenCenter for Medical Genetics, Ghent UniversityDirección de correo verificada de ugent.be
Maté OngenaertSenior scientist computational biology at Johnson & Johnson Innovative MedicineDirección de correo verificada de its.jnj.com
David LindgrenCenter for Molecular Pathology, Lund University, SwedenDirección de correo verificada de med.lu.se
Mary Helen Barcellos-HoffProfessor of Radiation Oncology, University of California, San FranciscoDirección de correo verificada de ucsf.edu
Charles M. PerouUniversity of North Carolina at Chapel HillDirección de correo verificada de med.unc.edu

Seguir

Erik Fredlund

Dept. Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden

Dirección de correo verificada de ki.se

Translational bioinformatics Personalized medicine Cancer biology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development P Kucharzewska, HC Christianson, JE Welch, KJ Svensson, E Fredlund, ... Proceedings of the National Academy of Sciences 110 (18), 7312-7317, 2013	969	2013
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype L Holmquist-Mengelbier, E Fredlund, T Löfstedt, R Noguera, S Navarro, ... Cancer cell 10 (5), 413-423, 2006	874	2006
GOBO: gene expression-based outcome for breast cancer online M Ringnér, E Fredlund, J Häkkinen, Å Borg, J Staaf PloS one 6 (3), e17911, 2011	416	2011
Hypoxia-induced dedifferentiation of tumor cells–a mechanism behind heterogeneity and aggressiveness of solid tumors H Axelson, E Fredlund, M Ovenberger, G Landberg, S Påhlman Seminars in cell & developmental biology 16 (4-5), 554-563, 2005	372	2005
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma P Mestdagh, AK Boström, F Impens, E Fredlund, G Van Peer, ... Molecular cell 40 (5), 762-773, 2010	358	2010
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer PMK Westcott, KD Halliwill, MD To, M Rashid, AG Rust, TM Keane, ... Nature 517 (7535), 489-492, 2015	350	2015
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia HY Fang, R Hughes, C Murdoch, SB Coffelt, SK Biswas, AL Harris, ... Blood, The Journal of the American Society of Hematology 114 (4), 844-859, 2009	343	2009
Pericyte–fibroblast transition promotes tumor growth and metastasis K Hosaka, Y Yang, T Seki, C Fischer, O Dubey, E Fredlund, J Hartman, ... Proceedings of the National Academy of Sciences 113 (38), E5618-E5627, 2016	315	2016
Hypoxia inducible factor-2α in cancer T Löfstedt, E Fredlund, L Holmquist-Mengelbier, A Pietras, M Ovenberger, ... Cell cycle 6 (8), 919-926, 2007	242	2007
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma E Fredlund, M Ringnér, JM Maris, S Påhlman Proceedings of the National Academy of Sciences 105 (37), 14094-14099, 2008	194	2008
SubCellBarCode: proteome-wide mapping of protein localization and relocalization LM Orre, M Vesterlund, Y Pan, T Arslan, Y Zhu, AF Woodbridge, O Frings, ... Molecular cell 73 (1), 166-182. e7, 2019	189	2019
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ... Oncotarget 6 (14), 12297, 2015	181	2015
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours P Mestdagh, E Fredlund, F Pattyn, A Rihani, T Van Maerken, J Vermeulen, ... Oncogene 29 (24), 3583-3592, 2010	178	2010
HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells A Pietras, LM Hansford, AS Johnsson, E Bridges, J Sjölund, D Gisselsson, ... Proceedings of the National Academy of Sciences 106 (39), 16805-16810, 2009	174	2009
Breast cancer quantitative proteome and proteogenomic landscape HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ... Nature communications 10 (1), 1600, 2019	171	2019
Hypoxia-inducible factor-2α correlates to distant recurrence and poor outcome in invasive breast cancer K Helczynska, AM Larsson, L Holmquist Mengelbier, E Bridges, ... Cancer research 68 (22), 9212-9220, 2008	169	2008
MYCN-regulated microRNAs repress estrogen receptor-α (ESR1) expression and neuronal differentiation in human neuroblastoma J Lovén, N Zinin, T Wahlström, I Müller, P Brodin, E Fredlund, U Ribacke, ... Proceedings of the National Academy of Sciences 107 (4), 1553-1558, 2010	158	2010
PARP1-and CTCF-mediated interactions between active and repressed chromatin at the lamina promote oscillating transcription H Zhao, EG Sifakis, N Sumida, L Millán-Ariño, BA Scholz, JP Svensson, ... Molecular cell 59 (6), 984-997, 2015	150	2015
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors P Mestdagh, E Fredlund, F Pattyn, JH Schulte, D Muth, J Vermeulen, ... Oncogene 29 (9), 1394-1404, 2010	150	2010
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth M Gerling, NVJA Büller, LM Kirn, S Joost, O Frings, B Englert, Å Bergström, ... Nature communications 7 (1), 12321, 2016	144	2016

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores